J 2022

Flavonoids exert potential in the management of hypertensive disorders in pregnancy

MAZURAKOVA, Alena, Lenka KOKLESOVA, Marek SAMEC, Erik KUDELA, Jana SIVAKOVA et. al.

Basic information

Original name

Flavonoids exert potential in the management of hypertensive disorders in pregnancy

Authors

MAZURAKOVA, Alena, Lenka KOKLESOVA, Marek SAMEC, Erik KUDELA, Jana SIVAKOVA, Terezia PRIBULOVA, Martin Jozef PEC, Martin PEC, Martin KELLO, Dietrich BUSSELBERG, Olga GOLUBNITSCHAJA, Ludovit GASPAR, Martin CAPRNDA, Mariusz ADAMEK, Robert PROSECKÝ (203 Czech Republic, belonging to the institution), Elmira EMINOVA, Denis BARANENKO, Peter KRUŽLIAK (703 Slovakia, guarantor, belonging to the institution), Peter KUBATKA and Kamil BIRINGER

Edition

PREGNANCY HYPERTENSION-AN INTERNATIONAL JOURNAL OF WOMENS CARDIOVASCULAR HEALTH, OXFORD, ELSEVIER SCI LTD, 2022, 2210-7789

Other information

Language

English

Type of outcome

Článek v odborném periodiku

Field of Study

30201 Cardiac and Cardiovascular systems

Country of publisher

United Kingdom of Great Britain and Northern Ireland

Confidentiality degree

není předmětem státního či obchodního tajemství

References:

Impact factor

Impact factor: 2.200

RIV identification code

RIV/00216224:14110/22:00128207

Organization unit

Faculty of Medicine

UT WoS

000835961500002

Keywords in English

Flavonoids; Hypertensive disorders; Pregnancy; Preeclampsia

Tags

International impact, Reviewed
Změněno: 11/1/2024 11:59, Mgr. Tereza Miškechová

Abstract

V originále

Hypertensive disorders in pregnancy represent severe complications of pregnancy, which, if not treated, can result in serious health consequences for the mother and the child. Flavonoids are bioactive secondary metabolites commonly found in fruits, vegetables, green tea, whole grains, and medicinal plants. Flavonoids exert potent protective efficacy in experimental models of hypertensive disorders in pregnancy, especially preeclampsia, demonstrated through their capacity to modulate inflammatory responses, oxidative stress, and vascular dysfunction. In addition to their potential as therapeutics, flavonoids or flavonoid-rich food could be helpful to decrease the risk of hypertensive disorders in pregnancy when included in the diet pattern before and during pregnancy. However, the clinical evaluation of the potential capacity of flavonoids in hypertensive disorders in pregnancy is insufficient. Due to promising results from experimental studies, we highlight the need for the evaluation of flavonoids also in an appropriate clinical setting, which can be, together with proper preventive strategies, helpful in the overall management of hypertensive disorders in pregnancy.